Ledger.Open graph →
SEC Form D · filed October 20, 2020

Aristea Therapeutics, Inc

Offering
$62.6M
Sold
$39.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Kenneth Harrison · San Diego, CADirectorCiara Kennedy · San Diego, CADirectorTiba Aynechi · San Diego, CADirectorJames Mackay · San Diego, CAExec · DirectorJoseph K. Cunningham · Sunrise, FLDirectorTroy P. Cunningham · Sunrise, FLExec · DirectorJohn Harris · Gardena, CADirectorPhillip Weicker · Gardena, CADirectorLauren Fundr Capital, Inc. Washington · Austin, TXExec · DirectorBradley Dillon · Littleton, CODirectorJohn Bruton · Dublin, IrelandDirectorJessica Eggins · Alpharetta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗